[SEPAR Recommendations for COVID-19 Vaccination in Patients With Respiratory Diseases]
- PMID: 38620748
- PMCID: PMC7983358
- DOI: 10.1016/j.opresp.2021.100097
[SEPAR Recommendations for COVID-19 Vaccination in Patients With Respiratory Diseases]
Abstract
The Spanish Society of Pneumonology and Thoracic Surgery (SEPAR) has elaborated this document of recommendations for COVID-19 vaccination in patients with respiratory diseases aimed to help healthcare personnel make decisions about how to act in case of COVID-19 vaccination in these patients.The recommendations have been developed by a group of experts in this field after reviewing the materials published up to March 7, 2021, the information provided by different scientific societies, drug agencies and the strategies of the governmental bodies up to this date.We can conclude that COVID-19 vaccines are not only safe and effective, but also prior in vulnerable patients with chronic respiratory diseases. In addition, an active involvement of healthcare professionals, who manage these diseases, in the vaccination strategy is the key to achieve good adherence and high vaccination coverage.
La Sociedad Española de Neumología y Cirugía Torácica (SEPAR) ha elaborado este documento de recomendaciones sobre la vacuna para la COVID-19 en las enfermedades respiratorias, con el objetivo de ayudar al personal sanitario en la toma de decisiones sobre cómo actuar en la vacunación de estos pacientes.
Las recomendaciones han sido elaboradas por un grupo de expertos en la materia, tras la revisión de la literatura recopilada hasta el 7 de marzo del 2021, y de la información aportada por distintas sociedades científicas, agencias del medicamento y estrategias de organismos gubernamentales hasta esa fecha.
Podemos concluir que las vacunas para la COVID-19 no solo son seguras y eficaces, sino que, en aquellos pacientes vulnerables con enfermedades respiratorias crónicas, son prioritarias. Además, la implicación activa de los profesionales sanitarios que manejan estas patologías en la estrategia de vacunación es clave para lograr una buena adherencia y coberturas vacunales elevadas.
Keywords: COVID-19; Recommendation; Respiratory; SARS-CoV-2; Vaccine.
© 2021 Sociedad Española de Neumología y Cirugía Torácica (SEPAR). Published by Elsevier España, S.L.U.
Similar articles
-
[Technical guidelines for seasonal influenza vaccination in China (2021-2022)].Zhonghua Liu Xing Bing Xue Za Zhi. 2021 Oct 10;42(10):1722-1749. doi: 10.3760/cma.j.cn112338-20210913-00732. Zhonghua Liu Xing Bing Xue Za Zhi. 2021. PMID: 34814607 Chinese.
-
Spanish Society of Hematology and Hemotherapy expert consensus opinion for SARS-CoV-2 vaccination in onco-hematological patients.Leuk Lymphoma. 2022 Mar;63(3):538-550. doi: 10.1080/10428194.2021.1992619. Epub 2021 Oct 20. Leuk Lymphoma. 2022. PMID: 34668835 Free PMC article.
-
A randomized, double-blind, placebo-controlled phase III clinical trial to evaluate the efficacy and safety of SARS-CoV-2 vaccine (inactivated, Vero cell): a structured summary of a study protocol for a randomised controlled trial.Trials. 2021 Apr 13;22(1):276. doi: 10.1186/s13063-021-05180-1. Trials. 2021. PMID: 33849629 Free PMC article.
-
[STIKO vaccination recommendations : Vaccination of immunodeficient patients and vaccination against COVID-19].Hautarzt. 2021 Feb;72(2):92-99. doi: 10.1007/s00105-021-04761-0. Epub 2021 Jan 18. Hautarzt. 2021. PMID: 33462654 Free PMC article. Review. German.
-
Clinical consensus recommendations regarding non-invasive respiratory support in the adult patient with acute respiratory failure secondary to SARS-CoV-2 infection.Med Intensiva (Engl Ed). 2020 Oct;44(7):429-438. doi: 10.1016/j.medin.2020.03.005. Epub 2020 Mar 30. Med Intensiva (Engl Ed). 2020. PMID: 32312600 Free PMC article. English, Spanish.
Cited by
-
Short-Term Adverse Effects of the Fourth Dose of Vaccination against COVID-19 in Adults over 40 Years of Age.Vaccines (Basel). 2024 Apr 10;12(4):400. doi: 10.3390/vaccines12040400. Vaccines (Basel). 2024. PMID: 38675782 Free PMC article.
References
-
- Doherty M., Buchy P., Standaert B., Giaquinto C., Prado-Cohrs D. Vaccine impact: Benefits for human health. Vaccine. 2016;34:6707–6714. - PubMed
-
- WHO Draft landscape and tracker of COVID-19 candidate vaccines. 2021 https://www.who.int/publications/m/item/draft-landscape-of-covid-19-cand....
-
- Villar-Álvarez F., López-Yeste P., Lazo-Meneses P. Fases clínicas de la COVID-19. Diagnóstico diferencial. Rev Patol Respir. 2020;23:S256–S262.
-
- Cordovilla R., Álvarez S., Llanos L., Nuñez-Ares A., Cases-Viedma E., Díaz-Pérez D., et al. SEPAR and AEER consensus recommendations on the Use of Bronchoscopy and Airway Sampling in Patients with Suspected or Confirmed COVID-19 Infection. Arch Bronconeumol. 2020;56:19–26.
Publication types
LinkOut - more resources
Full Text Sources
Miscellaneous